Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion

Ophthalmology

Volumn 120, Issue 4, 2013, Pages 795-802

  Campochiaro, Peter A ^a   Bhisitkul, Robert B ^b   Shapiro, Howard ^c   Rubio, Roman G ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; VASCULOTROPIN;

ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; DRUG EFFECT; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA DISEASE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA EDEMA; RETINAL NONPERFUSION; RETROSPECTIVE STUDY;

ANTIBODIES, MONOCLONAL, HUMANIZED; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; MACULAR EDEMA; RETINA; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84875752725     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.09.032     Document Type: Article

References (19)

1. P.A. Campochiaro, G. Hafiz, S.M. Shah Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator Mol Ther 16 2008 791 799
2. P.A. Campochiaro, J.S. Heier, L. Feiner BRAVO Investigators Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1102 1112
3. D.M. Brown, P.A. Campochiaro, R.P. Singh CRUISE Investigators Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1124 1133
4. D.M. Brown, P.A. Campochiaro, R.B. Bhisitkul Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study Ophthalmology 118 2011 1594 1602
5. P.A. Campochiaro, D.M. Brown, C.C. Awh Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study Ophthalmology 118 2011 2041 2049
6. SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 5 Arch Ophthalmol 127 2009 1101 1114
7. SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 6 Arch Ophthalmol 127 2009 1115 1128
8. Early Treatment Diabetic Retinopathy Study Research Group Classification of diabetic retinopathy from fluorescein angiograms: ETDRS report number 11 Ophthalmology 98 Suppl 1991 807 822
9. B.A. Blodi, A. Domalpally, I.U. Scott SCORE Study Research Group Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study report 9 Arch Ophthalmol 128 2010 1140 1145
10. C.K. Chan, M.S. Ip, P.C. Vanveldhuisen SCORE Study Investigator Group SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion Ophthalmology 118 2011 1364 1372
11. E.J. Sabet-Peyman, F.M. Heussen, J.E. Thorne Progressive macular ischemia following intravitreal bevacizumab Ophthalmic Surg Lasers Imaging 40 2009 316 318
12. A.M. Mansour, L.A. Bynoe, J.C. Welch Retinal vascular events after intravitreal bevacizumab Acta Ophthalmol 88 2010 730 735
13. M. Shimura, K. Yasuda Macular ischaemia after intravitreal bevacizumab injection in patients with central retinal vein occlusion and a history of diabetes and vascular disease [letter] Br J Ophthalmol 94 2010 381 383
14. N.R. Kim, H.S. Chin Progression of impending central retinal vein occlusion to the ischemic variant following intravitreal bevacizumab Korean J Ophthalmol 24 2010 179 181
15. M. Battaglia Parodi, P. Iacono, M.L. Cascavilla Sequential anterior ischemic optic neuropathy and central retinal artery and vein occlusion after ranibizumab for diabetic macular edema Eur J Ophthalmol 20 2010 1076 1078
16. T. Terui, M. Kondo, T. Sugita Changes in areas of capillary nonperfusion after intravitreal injection of bevacizumab in eyes with branch vein occlusion Retina 31 2011 1068 1074
17. N. Goel, V. Kumar, B. Ghosh Ischemic maculopathy following intravitreal bevacizumab for refractory diabetic macular edema Int Ophthalmol 31 2011 39 42
18. S.S. Hayreh Occlusion of the central retinal vessels Br J Ophthalmol 49 1965 626 645
19. M.J. Tolentino, J.W. Miller, E.S. Gragoudas Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate Ophthalmology 103 1996 1820 1828